Inhibition of cytosolic and mitochondrial creatine kinase by siRNA in HaCaT- and HeLaS3-cells affects cell viability and mitochondrial morphology. 2007

Holger Lenz, and Melanie Schmidt, and Vivienne Welge, and Thomas Kueper, and Uwe Schlattner, and Theo Wallimann, and Hans-Peter Elsässer, and Klaus-Peter Wittern, and Horst Wenck, and Franz Staeb, and Thomas Blatt
R&D, Beiersdorf AG, Unnastrasse 48, 20245 Hamburg, Germany. holger.lenz@beiersdorf.com

The creatine kinase (CK) system is essential for cellular energetics in tissues or cells with high and fluctuating energy requirements. Creatine itself is known to protect cells from stress-induced injury. By using an siRNA approach to silence the CK isoenzymes in human keratinocyte HaCaT cells, expressing low levels of cytoplasmic CK and high levels of mitochondrial CK, as well as HeLa cancer cells, expressing high levels of cytoplasmic CK and low levels of mitochondrial CK, we successfully lowered the respective CK expression levels and studied the effects of either abolishing cytosolic brain-type BB-CK or ubiquitous mitochondrial uMi-CK in these cells. In both cell lines, targeting the dominant CK isoform by the respective siRNAs had the strongest effect on overall CK activity. However, irrespective of the expression level in both cell lines, inhibition of the mitochondrial CK isoform generally caused the strongest decline in cell viability and cell proliferation. These findings are congruent with electron microscopic data showing substantial alteration of mitochondrial morphology as well as mitochondrial membrane topology after targeting uMi-CK in both cell lines. Only for the rate of apoptosis, it was the least expressed CK present in each of the cell lines whose inhibition led to the highest proportion of apoptotic cells, i.e., downregulation of uMi-CK in case of HeLaS3 and BB-CK in case of HaCaT cells. We conclude from these data that a major phenotype is linked to reduction of mitochondrial CK alone or in combination with cytosolic CK, and that this effect is independent of the relative expression levels of Mi-CK in the cell type considered. The mitochondrial CK isoform appears to play the most crucial role in maintaining cell viability by stabilizing contact sites between inner and outer mitochondrial membranes and maintaining local metabolite channeling, thus avoiding transition pore opening which eventually results in activation of caspase cell-death pathways.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D010725 Phosphocreatine An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996) Creatine Phosphate,Neoton,Phosphocreatine, Disodium Salt,Phosphorylcreatine,Disodium Salt Phosphocreatine,Phosphate, Creatine
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015603 Keratinocytes Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell. Keratinocyte

Related Publications

Holger Lenz, and Melanie Schmidt, and Vivienne Welge, and Thomas Kueper, and Uwe Schlattner, and Theo Wallimann, and Hans-Peter Elsässer, and Klaus-Peter Wittern, and Horst Wenck, and Franz Staeb, and Thomas Blatt
June 1996, Biochimica et biophysica acta,
Holger Lenz, and Melanie Schmidt, and Vivienne Welge, and Thomas Kueper, and Uwe Schlattner, and Theo Wallimann, and Hans-Peter Elsässer, and Klaus-Peter Wittern, and Horst Wenck, and Franz Staeb, and Thomas Blatt
January 1985, Enzyme,
Holger Lenz, and Melanie Schmidt, and Vivienne Welge, and Thomas Kueper, and Uwe Schlattner, and Theo Wallimann, and Hans-Peter Elsässer, and Klaus-Peter Wittern, and Horst Wenck, and Franz Staeb, and Thomas Blatt
September 1997, Molecular and cellular biochemistry,
Holger Lenz, and Melanie Schmidt, and Vivienne Welge, and Thomas Kueper, and Uwe Schlattner, and Theo Wallimann, and Hans-Peter Elsässer, and Klaus-Peter Wittern, and Horst Wenck, and Franz Staeb, and Thomas Blatt
April 2024, bioRxiv : the preprint server for biology,
Holger Lenz, and Melanie Schmidt, and Vivienne Welge, and Thomas Kueper, and Uwe Schlattner, and Theo Wallimann, and Hans-Peter Elsässer, and Klaus-Peter Wittern, and Horst Wenck, and Franz Staeb, and Thomas Blatt
February 1997, Molecular and cellular biochemistry,
Holger Lenz, and Melanie Schmidt, and Vivienne Welge, and Thomas Kueper, and Uwe Schlattner, and Theo Wallimann, and Hans-Peter Elsässer, and Klaus-Peter Wittern, and Horst Wenck, and Franz Staeb, and Thomas Blatt
July 1998, Molecular and cellular biochemistry,
Holger Lenz, and Melanie Schmidt, and Vivienne Welge, and Thomas Kueper, and Uwe Schlattner, and Theo Wallimann, and Hans-Peter Elsässer, and Klaus-Peter Wittern, and Horst Wenck, and Franz Staeb, and Thomas Blatt
May 1996, Biochimica et biophysica acta,
Holger Lenz, and Melanie Schmidt, and Vivienne Welge, and Thomas Kueper, and Uwe Schlattner, and Theo Wallimann, and Hans-Peter Elsässer, and Klaus-Peter Wittern, and Horst Wenck, and Franz Staeb, and Thomas Blatt
May 2009, Basic research in cardiology,
Holger Lenz, and Melanie Schmidt, and Vivienne Welge, and Thomas Kueper, and Uwe Schlattner, and Theo Wallimann, and Hans-Peter Elsässer, and Klaus-Peter Wittern, and Horst Wenck, and Franz Staeb, and Thomas Blatt
April 1997, Cell,
Holger Lenz, and Melanie Schmidt, and Vivienne Welge, and Thomas Kueper, and Uwe Schlattner, and Theo Wallimann, and Hans-Peter Elsässer, and Klaus-Peter Wittern, and Horst Wenck, and Franz Staeb, and Thomas Blatt
May 2003, The Journal of physiology,
Copied contents to your clipboard!